|
| |
Image Results
Loading...
Loading...
Boston Biomedica Incorporated Pages on BioPortfolio:
|
BioPortfolio - Oxford Biomedica - OXFORD BIOMEDICA SIGNS LICENSE ...
Boston University and Dana-Farber Cancer Institute extending the field of Oxford BioMedica's ... subsidiary, BioMedica Inc, in San Diego, California. ...
http://www.bioportfolio.com/news/OXFORD_BIOMEDICA_SIGNS_LICE...
|
BioPortfolio - Oxford BioMedica - Profile
View the current Oxford BioMedica Page on BioPortfolio.com .... Inc. BOSTON, Nov . 2 /PRNewswire/. -- UCL Liver Failure Group presented data from two studies ...
http://www.bioportfolio.com/biocorporate/7964-Oxford%2525252...
|
BioPortfolio - Chagas Cardiomyopathy
Catedra de Fisica Biomedica, Universidad Nacional de Cordoba. ... Project Pacer International, Boston, Massachusetts, USA. ... Institute (IDRI) and Chembio
Diagnostics Systems, Inc. (Chembio) today announced they have entered into a ...
http://www.bioportfolio.com/indepth/Chagas_Cardiomyopathy.ht...
|
BioPortfolio Biotechnology and Pharmaceutical News July to ...
Thrombotargets Corp. and Magellan Bioscience Group, Inc. to collaborate on identification of novel hits from both marine ... OXFORD BIOMEDICA SECURES
RIGHTS TO ENDOSTATIN AND ANGIOSTATIN GENES FOR CANCER FROM CHILDREN'S HOSPITAL
BOSTON ...
http://www.bioportfolio.com/biotech_news/july_to_september_2...
|
BioPortfolio Client Press Releases Site Map
Oxford Biomedica Receives Notice Of Allowance For Us Lentivector® Patent ...... research collaboration with Novartis Institutes for BioMedical Research, Inc.
...... Biotech Tracker News - Boston Scientific Presents Additional Coated ...
http://www.bioportfolio.com/news/site_map.htm...
|
Biotechnology and Pharmaceutical News Site Map
OXFORD BIOMEDICA REPORT ENCOURAGING NEW PHASE II TRIAL RESULTS WITH TROVAX ..... Thrombotargets Corp. and Magellan Bioscience Group, Inc. to collaborate on ...
FROM CHILDREN'S HOSPITAL BOSTON · EMEA approves Kamada's plans for phase II ...
http://www.bioportfolio.com/biotech_news/site_map.htm...
| Results from other life science and pharmaceutical sites:
BioSpace - Boston Biomedica, Inc. News, Search Jobs, Events
19 Oct 2005 ... Boston Biomedica, Inc. provides products and services for the detection and monitoring of infectious diseases such as AIDS and Viral ...
http://www.biospace.com/company_profile.aspx?CompanyID=1315...
|
Boston Biomedica, Inc.
Boston Biomedica, Inc. West Bridgewater, MA. SoGAT. Langen, Germany. July 3, 2003 .... Boston Biomedica Inc. Alan Doty. Barbara Weiblen. Harmesh Sharma ...
http://www.nibsc.ac.uk/sogat/2003_presentations/Manak%20WNV%...
|
A Multicenter Study Evaluation of the Digene Hybrid Capture II ...
Specimens used for the multicenter evaluation were well-characterized samples obtained from a commercial manufacturer (Boston Biomedica Incorporated, ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC86750/...
|
510k Summary of Safety and Effectiveness: BK040006, ACCURUN 315 ...
Boston Biomédica, Inc. BK040006. 510(k) Notification: Summary of Safety and Effectiveness. ACCURUN* 315 HIV-1 RNA Positive Quality Control ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
Whole-Blood Agglutination Assay for On-Site Detection of Human ...
Mixed-titer serum panels and seroconversion panels were purchased from Boston Biomedica Inc. (Westbridgewater, Mass.) and NABI Biopharmaceuticals (Boca ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC165333/...
|
510k Summary: BK40067 Accurun 803 Nucleic Acid Negative Quality ...
Boston Biomédica, Inc. 510(k) Notification: Summary of Safety aind Effectiveness . ACCURUN* 803 Nucleic Acid Negative Cîuality Control (HIV.HCV.HBV) ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
Significant Closure of the Human Immunodeficiency Virus Type 1 and ...
Fourteen HIV-1 seroconversion panels were acquired from Boston Biomedica, Inc. ( BBI; West Bridgewater, Mass.): panels PRB916, PRB923, PRB926, PRB929, ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC130666/...
|
BK040064 510(k) Summary: Accurun 345 RNA, HCV RNA, HBV DNA ...
Boston Biomédica, Inc. 510(10 Notification: Summary of Safely and Effectiveness. ACCURUN" 345 HIV-1 RNA, IICV RNA, HUV DNA Posilive Quality Control, ...
http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBlo...
|
European Proficiency Testing Program for Molecular Detection and ...
The panels were designed by the European Union Quality Control Concerted Action, prepared by Boston Biomedica, Inc., and distributed in May 1999 (panel 1) ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC88557/...
|
{1} Announces The Appointment Of Richard T. Schumacher As ...
Mr. R. Wayne Fritzsche, Chairman of the Board of Boston Biomedica, Inc., ... About Boston Biomedica, Inc. BBI provides products and services to the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1581472...
|
|
